Litcius/Paper detail

Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial

Susan E. Collins, Mark Duncan, Andrew J. Saxon, Emily Taylor, Nigel Mayberry, Joseph O. Merrill, Gail Hoffmann, Seema L. Clifasefi, Richard K. Ries

2021The Lancet Psychiatry53 citationsDOIOpen Access PDF

Topics & Concepts

Alcohol use disorderNaltrexoneAbstinencePlaceboPsychiatryHarm reductionMedicinePopulationAlcohol dependenceRandomized controlled trialPsychologyAlcoholPublic healthInternal medicineAlternative medicineEnvironmental healthPathologyReceptorChemistryBiochemistryOpioidNursingHomelessness and Social IssuesSubstance Abuse Treatment and OutcomesHIV, Drug Use, Sexual Risk
Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial | Litcius